nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—ABCB1—lung cancer	0.314	1	CbGaD
Terazosin—ABCB1—Topotecan—lung cancer	0.0502	0.136	CbGbCtD
Terazosin—ABCB1—Gefitinib—lung cancer	0.0459	0.124	CbGbCtD
Terazosin—ABCB1—Vinorelbine—lung cancer	0.0353	0.0958	CbGbCtD
Terazosin—ABCB1—Crizotinib—lung cancer	0.0281	0.0762	CbGbCtD
Terazosin—ABCB1—Gemcitabine—lung cancer	0.0275	0.0745	CbGbCtD
Terazosin—ABCB1—Erlotinib—lung cancer	0.0271	0.0735	CbGbCtD
Terazosin—ABCB1—Paclitaxel—lung cancer	0.0248	0.0673	CbGbCtD
Terazosin—ABCB1—Irinotecan—lung cancer	0.0245	0.0664	CbGbCtD
Terazosin—ABCB1—Vinblastine—lung cancer	0.0218	0.059	CbGbCtD
Terazosin—ABCB1—Cisplatin—lung cancer	0.02	0.0541	CbGbCtD
Terazosin—ABCB1—Etoposide—lung cancer	0.0196	0.0532	CbGbCtD
Terazosin—ABCB1—Docetaxel—lung cancer	0.018	0.0486	CbGbCtD
Terazosin—ABCB1—Doxorubicin—lung cancer	0.0134	0.0363	CbGbCtD
Terazosin—ABCB1—Methotrexate—lung cancer	0.013	0.0351	CbGbCtD
Terazosin—Prazosin—MT3—lung cancer	0.00573	0.655	CrCbGaD
Terazosin—Prazosin—ABCG2—lung cancer	0.00114	0.13	CrCbGaD
Terazosin—Prazosin—CYP1A1—lung cancer	0.000891	0.102	CrCbGaD
Terazosin—Doxazosin—ABCB1—lung cancer	0.000514	0.0587	CrCbGaD
Terazosin—Prazosin—ABCB1—lung cancer	0.000473	0.0541	CrCbGaD
Terazosin—Hyperhidrosis—Paclitaxel—lung cancer	0.000202	0.000794	CcSEcCtD
Terazosin—Nasopharyngitis—Doxorubicin—lung cancer	0.000201	0.00079	CcSEcCtD
Terazosin—Depression—Methotrexate—lung cancer	0.0002	0.000784	CcSEcCtD
Terazosin—Anorexia—Paclitaxel—lung cancer	0.000199	0.000783	CcSEcCtD
Terazosin—Hypotension—Etoposide—lung cancer	0.000199	0.000782	CcSEcCtD
Terazosin—Gastritis—Doxorubicin—lung cancer	0.000199	0.000782	CcSEcCtD
Terazosin—Pain—Cisplatin—lung cancer	0.000199	0.000782	CcSEcCtD
Terazosin—Vomiting—Vinorelbine—lung cancer	0.000198	0.000776	CcSEcCtD
Terazosin—Body temperature increased—Gemcitabine—lung cancer	0.000198	0.000775	CcSEcCtD
Terazosin—Rash—Vinorelbine—lung cancer	0.000196	0.00077	CcSEcCtD
Terazosin—Dermatitis—Vinorelbine—lung cancer	0.000196	0.000769	CcSEcCtD
Terazosin—Hypotension—Paclitaxel—lung cancer	0.000195	0.000767	CcSEcCtD
Terazosin—Headache—Vinorelbine—lung cancer	0.000195	0.000765	CcSEcCtD
Terazosin—Syncope—Docetaxel—lung cancer	0.000195	0.000765	CcSEcCtD
Terazosin—Conjunctivitis—Methotrexate—lung cancer	0.000195	0.000764	CcSEcCtD
Terazosin—Asthma—Doxorubicin—lung cancer	0.000195	0.000764	CcSEcCtD
Terazosin—Influenza—Doxorubicin—lung cancer	0.000195	0.000764	CcSEcCtD
Terazosin—Sweating—Methotrexate—lung cancer	0.000192	0.000754	CcSEcCtD
Terazosin—Palpitations—Docetaxel—lung cancer	0.000192	0.000753	CcSEcCtD
Terazosin—Feeling abnormal—Cisplatin—lung cancer	0.000192	0.000753	CcSEcCtD
Terazosin—Paraesthesia—Etoposide—lung cancer	0.000192	0.000752	CcSEcCtD
Terazosin—Loss of consciousness—Docetaxel—lung cancer	0.000191	0.000749	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000191	0.000748	CcSEcCtD
Terazosin—Dyspnoea—Etoposide—lung cancer	0.00019	0.000746	CcSEcCtD
Terazosin—Somnolence—Etoposide—lung cancer	0.00019	0.000744	CcSEcCtD
Terazosin—Cough—Docetaxel—lung cancer	0.00019	0.000744	CcSEcCtD
Terazosin—Angina pectoris—Doxorubicin—lung cancer	0.00019	0.000744	CcSEcCtD
Terazosin—Insomnia—Paclitaxel—lung cancer	0.000189	0.000743	CcSEcCtD
Terazosin—Epistaxis—Methotrexate—lung cancer	0.000189	0.000742	CcSEcCtD
Terazosin—Hypersensitivity—Irinotecan—lung cancer	0.000189	0.000742	CcSEcCtD
Terazosin—Convulsion—Docetaxel—lung cancer	0.000188	0.000739	CcSEcCtD
Terazosin—Paraesthesia—Paclitaxel—lung cancer	0.000188	0.000737	CcSEcCtD
Terazosin—Bronchitis—Doxorubicin—lung cancer	0.000187	0.000734	CcSEcCtD
Terazosin—Dyspnoea—Paclitaxel—lung cancer	0.000187	0.000732	CcSEcCtD
Terazosin—Somnolence—Paclitaxel—lung cancer	0.000186	0.00073	CcSEcCtD
Terazosin—Decreased appetite—Etoposide—lung cancer	0.000185	0.000728	CcSEcCtD
Terazosin—Arthralgia—Docetaxel—lung cancer	0.000185	0.000726	CcSEcCtD
Terazosin—Chest pain—Docetaxel—lung cancer	0.000185	0.000726	CcSEcCtD
Terazosin—Myalgia—Docetaxel—lung cancer	0.000185	0.000726	CcSEcCtD
Terazosin—Nausea—Vinorelbine—lung cancer	0.000185	0.000725	CcSEcCtD
Terazosin—Dyspepsia—Paclitaxel—lung cancer	0.000184	0.000723	CcSEcCtD
Terazosin—Body temperature increased—Cisplatin—lung cancer	0.000184	0.000722	CcSEcCtD
Terazosin—Asthenia—Irinotecan—lung cancer	0.000184	0.000722	CcSEcCtD
Terazosin—Fatigue—Etoposide—lung cancer	0.000184	0.000722	CcSEcCtD
Terazosin—Pain—Etoposide—lung cancer	0.000182	0.000716	CcSEcCtD
Terazosin—Constipation—Etoposide—lung cancer	0.000182	0.000716	CcSEcCtD
Terazosin—Dysuria—Doxorubicin—lung cancer	0.000182	0.000714	CcSEcCtD
Terazosin—Decreased appetite—Paclitaxel—lung cancer	0.000182	0.000714	CcSEcCtD
Terazosin—Dry mouth—Docetaxel—lung cancer	0.000181	0.00071	CcSEcCtD
Terazosin—Fatigue—Paclitaxel—lung cancer	0.00018	0.000708	CcSEcCtD
Terazosin—Pollakiuria—Doxorubicin—lung cancer	0.00018	0.000705	CcSEcCtD
Terazosin—Asthenia—Gemcitabine—lung cancer	0.000179	0.000704	CcSEcCtD
Terazosin—Constipation—Paclitaxel—lung cancer	0.000179	0.000702	CcSEcCtD
Terazosin—Pain—Paclitaxel—lung cancer	0.000179	0.000702	CcSEcCtD
Terazosin—Confusional state—Docetaxel—lung cancer	0.000179	0.000702	CcSEcCtD
Terazosin—Pharyngitis—Methotrexate—lung cancer	0.000179	0.000701	CcSEcCtD
Terazosin—Photosensitivity reaction—Doxorubicin—lung cancer	0.000178	0.000697	CcSEcCtD
Terazosin—Anaphylactic shock—Docetaxel—lung cancer	0.000177	0.000696	CcSEcCtD
Terazosin—Oedema—Docetaxel—lung cancer	0.000177	0.000696	CcSEcCtD
Terazosin—Weight increased—Doxorubicin—lung cancer	0.000177	0.000695	CcSEcCtD
Terazosin—Pruritus—Gemcitabine—lung cancer	0.000177	0.000694	CcSEcCtD
Terazosin—Feeling abnormal—Etoposide—lung cancer	0.000176	0.00069	CcSEcCtD
Terazosin—Diarrhoea—Irinotecan—lung cancer	0.000176	0.000689	CcSEcCtD
Terazosin—Gastrointestinal pain—Etoposide—lung cancer	0.000174	0.000685	CcSEcCtD
Terazosin—Shock—Docetaxel—lung cancer	0.000174	0.000685	CcSEcCtD
Terazosin—Thrombocytopenia—Docetaxel—lung cancer	0.000174	0.000681	CcSEcCtD
Terazosin—Visual impairment—Methotrexate—lung cancer	0.000173	0.00068	CcSEcCtD
Terazosin—Tachycardia—Docetaxel—lung cancer	0.000173	0.000679	CcSEcCtD
Terazosin—Feeling abnormal—Paclitaxel—lung cancer	0.000172	0.000677	CcSEcCtD
Terazosin—Hypersensitivity—Cisplatin—lung cancer	0.000172	0.000673	CcSEcCtD
Terazosin—Gastrointestinal pain—Paclitaxel—lung cancer	0.000171	0.000671	CcSEcCtD
Terazosin—Diarrhoea—Gemcitabine—lung cancer	0.000171	0.000671	CcSEcCtD
Terazosin—Dizziness—Irinotecan—lung cancer	0.00017	0.000666	CcSEcCtD
Terazosin—Jaundice—Doxorubicin—lung cancer	0.000169	0.000664	CcSEcCtD
Terazosin—Anorexia—Docetaxel—lung cancer	0.000169	0.000663	CcSEcCtD
Terazosin—Abdominal pain—Etoposide—lung cancer	0.000169	0.000662	CcSEcCtD
Terazosin—Body temperature increased—Etoposide—lung cancer	0.000169	0.000662	CcSEcCtD
Terazosin—Conjunctivitis—Doxorubicin—lung cancer	0.000169	0.000662	CcSEcCtD
Terazosin—Urinary tract infection—Doxorubicin—lung cancer	0.000169	0.000662	CcSEcCtD
Terazosin—Eye disorder—Methotrexate—lung cancer	0.000168	0.00066	CcSEcCtD
Terazosin—Tinnitus—Methotrexate—lung cancer	0.000168	0.000658	CcSEcCtD
Terazosin—Asthenia—Cisplatin—lung cancer	0.000167	0.000656	CcSEcCtD
Terazosin—Sweating—Doxorubicin—lung cancer	0.000166	0.000653	CcSEcCtD
Terazosin—Hypotension—Docetaxel—lung cancer	0.000166	0.00065	CcSEcCtD
Terazosin—Abdominal pain—Paclitaxel—lung cancer	0.000165	0.000649	CcSEcCtD
Terazosin—Body temperature increased—Paclitaxel—lung cancer	0.000165	0.000649	CcSEcCtD
Terazosin—Epistaxis—Doxorubicin—lung cancer	0.000164	0.000642	CcSEcCtD
Terazosin—Vomiting—Irinotecan—lung cancer	0.000163	0.00064	CcSEcCtD
Terazosin—Sinusitis—Doxorubicin—lung cancer	0.000163	0.000639	CcSEcCtD
Terazosin—Rash—Irinotecan—lung cancer	0.000162	0.000635	CcSEcCtD
Terazosin—Dermatitis—Irinotecan—lung cancer	0.000162	0.000634	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000162	0.000634	CcSEcCtD
Terazosin—Headache—Irinotecan—lung cancer	0.000161	0.000631	CcSEcCtD
Terazosin—Insomnia—Docetaxel—lung cancer	0.00016	0.000629	CcSEcCtD
Terazosin—Diarrhoea—Cisplatin—lung cancer	0.000159	0.000625	CcSEcCtD
Terazosin—Paraesthesia—Docetaxel—lung cancer	0.000159	0.000625	CcSEcCtD
Terazosin—Vomiting—Gemcitabine—lung cancer	0.000159	0.000623	CcSEcCtD
Terazosin—Dyspnoea—Docetaxel—lung cancer	0.000158	0.00062	CcSEcCtD
Terazosin—Somnolence—Docetaxel—lung cancer	0.000158	0.000619	CcSEcCtD
Terazosin—Rash—Gemcitabine—lung cancer	0.000158	0.000618	CcSEcCtD
Terazosin—Dermatitis—Gemcitabine—lung cancer	0.000157	0.000618	CcSEcCtD
Terazosin—Hypersensitivity—Etoposide—lung cancer	0.000157	0.000617	CcSEcCtD
Terazosin—Malnutrition—Methotrexate—lung cancer	0.000157	0.000615	CcSEcCtD
Terazosin—Headache—Gemcitabine—lung cancer	0.000157	0.000614	CcSEcCtD
Terazosin—Rhinitis—Doxorubicin—lung cancer	0.000156	0.000613	CcSEcCtD
Terazosin—Dyspepsia—Docetaxel—lung cancer	0.000156	0.000613	CcSEcCtD
Terazosin—Pharyngitis—Doxorubicin—lung cancer	0.000155	0.000607	CcSEcCtD
Terazosin—Decreased appetite—Docetaxel—lung cancer	0.000154	0.000605	CcSEcCtD
Terazosin—Hypersensitivity—Paclitaxel—lung cancer	0.000154	0.000605	CcSEcCtD
Terazosin—Oedema peripheral—Doxorubicin—lung cancer	0.000153	0.000602	CcSEcCtD
Terazosin—Dysgeusia—Methotrexate—lung cancer	0.000153	0.000602	CcSEcCtD
Terazosin—Asthenia—Etoposide—lung cancer	0.000153	0.000601	CcSEcCtD
Terazosin—Fatigue—Docetaxel—lung cancer	0.000153	0.0006	CcSEcCtD
Terazosin—Nausea—Irinotecan—lung cancer	0.000152	0.000598	CcSEcCtD
Terazosin—Pain—Docetaxel—lung cancer	0.000152	0.000595	CcSEcCtD
Terazosin—Constipation—Docetaxel—lung cancer	0.000152	0.000595	CcSEcCtD
Terazosin—Back pain—Methotrexate—lung cancer	0.000151	0.000594	CcSEcCtD
Terazosin—Pruritus—Etoposide—lung cancer	0.000151	0.000592	CcSEcCtD
Terazosin—Visual impairment—Doxorubicin—lung cancer	0.00015	0.000589	CcSEcCtD
Terazosin—Asthenia—Paclitaxel—lung cancer	0.00015	0.000589	CcSEcCtD
Terazosin—Nausea—Gemcitabine—lung cancer	0.000148	0.000582	CcSEcCtD
Terazosin—Vomiting—Cisplatin—lung cancer	0.000148	0.000581	CcSEcCtD
Terazosin—Pruritus—Paclitaxel—lung cancer	0.000148	0.000581	CcSEcCtD
Terazosin—Vision blurred—Methotrexate—lung cancer	0.000148	0.000579	CcSEcCtD
Terazosin—Rash—Cisplatin—lung cancer	0.000147	0.000576	CcSEcCtD
Terazosin—Dermatitis—Cisplatin—lung cancer	0.000147	0.000576	CcSEcCtD
Terazosin—Feeling abnormal—Docetaxel—lung cancer	0.000146	0.000573	CcSEcCtD
Terazosin—Diarrhoea—Etoposide—lung cancer	0.000146	0.000573	CcSEcCtD
Terazosin—Eye disorder—Doxorubicin—lung cancer	0.000146	0.000571	CcSEcCtD
Terazosin—Ill-defined disorder—Methotrexate—lung cancer	0.000145	0.00057	CcSEcCtD
Terazosin—Tinnitus—Doxorubicin—lung cancer	0.000145	0.00057	CcSEcCtD
Terazosin—Gastrointestinal pain—Docetaxel—lung cancer	0.000145	0.000569	CcSEcCtD
Terazosin—Diarrhoea—Paclitaxel—lung cancer	0.000143	0.000562	CcSEcCtD
Terazosin—Malaise—Methotrexate—lung cancer	0.000141	0.000554	CcSEcCtD
Terazosin—Dizziness—Etoposide—lung cancer	0.000141	0.000554	CcSEcCtD
Terazosin—Vertigo—Methotrexate—lung cancer	0.000141	0.000552	CcSEcCtD
Terazosin—Abdominal pain—Docetaxel—lung cancer	0.00014	0.00055	CcSEcCtD
Terazosin—Body temperature increased—Docetaxel—lung cancer	0.00014	0.00055	CcSEcCtD
Terazosin—Arrhythmia—Doxorubicin—lung cancer	0.000139	0.000546	CcSEcCtD
Terazosin—Dizziness—Paclitaxel—lung cancer	0.000138	0.000543	CcSEcCtD
Terazosin—Nausea—Cisplatin—lung cancer	0.000138	0.000543	CcSEcCtD
Terazosin—Cough—Methotrexate—lung cancer	0.000137	0.000536	CcSEcCtD
Terazosin—Convulsion—Methotrexate—lung cancer	0.000136	0.000532	CcSEcCtD
Terazosin—Vomiting—Etoposide—lung cancer	0.000136	0.000532	CcSEcCtD
Terazosin—Malnutrition—Doxorubicin—lung cancer	0.000136	0.000532	CcSEcCtD
Terazosin—Rash—Etoposide—lung cancer	0.000135	0.000528	CcSEcCtD
Terazosin—Dermatitis—Etoposide—lung cancer	0.000134	0.000527	CcSEcCtD
Terazosin—Headache—Etoposide—lung cancer	0.000134	0.000525	CcSEcCtD
Terazosin—Flatulence—Doxorubicin—lung cancer	0.000134	0.000524	CcSEcCtD
Terazosin—Arthralgia—Methotrexate—lung cancer	0.000133	0.000523	CcSEcCtD
Terazosin—Myalgia—Methotrexate—lung cancer	0.000133	0.000523	CcSEcCtD
Terazosin—Chest pain—Methotrexate—lung cancer	0.000133	0.000523	CcSEcCtD
Terazosin—Tension—Doxorubicin—lung cancer	0.000133	0.000522	CcSEcCtD
Terazosin—Vomiting—Paclitaxel—lung cancer	0.000133	0.000522	CcSEcCtD
Terazosin—Dysgeusia—Doxorubicin—lung cancer	0.000133	0.000521	CcSEcCtD
Terazosin—Rash—Paclitaxel—lung cancer	0.000132	0.000518	CcSEcCtD
Terazosin—Dermatitis—Paclitaxel—lung cancer	0.000132	0.000517	CcSEcCtD
Terazosin—Discomfort—Methotrexate—lung cancer	0.000132	0.000517	CcSEcCtD
Terazosin—Nervousness—Doxorubicin—lung cancer	0.000132	0.000517	CcSEcCtD
Terazosin—Back pain—Doxorubicin—lung cancer	0.000131	0.000515	CcSEcCtD
Terazosin—Headache—Paclitaxel—lung cancer	0.000131	0.000514	CcSEcCtD
Terazosin—Hypersensitivity—Docetaxel—lung cancer	0.000131	0.000513	CcSEcCtD
Terazosin—Confusional state—Methotrexate—lung cancer	0.000129	0.000506	CcSEcCtD
Terazosin—Anaphylactic shock—Methotrexate—lung cancer	0.000128	0.000502	CcSEcCtD
Terazosin—Vision blurred—Doxorubicin—lung cancer	0.000128	0.000501	CcSEcCtD
Terazosin—Asthenia—Docetaxel—lung cancer	0.000127	0.000499	CcSEcCtD
Terazosin—Nausea—Etoposide—lung cancer	0.000127	0.000497	CcSEcCtD
Terazosin—Ill-defined disorder—Doxorubicin—lung cancer	0.000126	0.000494	CcSEcCtD
Terazosin—Pruritus—Docetaxel—lung cancer	0.000125	0.000492	CcSEcCtD
Terazosin—Thrombocytopenia—Methotrexate—lung cancer	0.000125	0.000491	CcSEcCtD
Terazosin—Nausea—Paclitaxel—lung cancer	0.000124	0.000488	CcSEcCtD
Terazosin—Hyperhidrosis—Methotrexate—lung cancer	0.000124	0.000485	CcSEcCtD
Terazosin—Malaise—Doxorubicin—lung cancer	0.000122	0.00048	CcSEcCtD
Terazosin—Vertigo—Doxorubicin—lung cancer	0.000122	0.000478	CcSEcCtD
Terazosin—Anorexia—Methotrexate—lung cancer	0.000122	0.000478	CcSEcCtD
Terazosin—Syncope—Doxorubicin—lung cancer	0.000122	0.000477	CcSEcCtD
Terazosin—Diarrhoea—Docetaxel—lung cancer	0.000121	0.000476	CcSEcCtD
Terazosin—Palpitations—Doxorubicin—lung cancer	0.00012	0.00047	CcSEcCtD
Terazosin—Hypotension—Methotrexate—lung cancer	0.000119	0.000469	CcSEcCtD
Terazosin—Loss of consciousness—Doxorubicin—lung cancer	0.000119	0.000468	CcSEcCtD
Terazosin—Cough—Doxorubicin—lung cancer	0.000118	0.000464	CcSEcCtD
Terazosin—Convulsion—Doxorubicin—lung cancer	0.000117	0.000461	CcSEcCtD
Terazosin—Dizziness—Docetaxel—lung cancer	0.000117	0.00046	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000116	0.000457	CcSEcCtD
Terazosin—Insomnia—Methotrexate—lung cancer	0.000116	0.000454	CcSEcCtD
Terazosin—Arthralgia—Doxorubicin—lung cancer	0.000115	0.000453	CcSEcCtD
Terazosin—Chest pain—Doxorubicin—lung cancer	0.000115	0.000453	CcSEcCtD
Terazosin—Myalgia—Doxorubicin—lung cancer	0.000115	0.000453	CcSEcCtD
Terazosin—Anxiety—Doxorubicin—lung cancer	0.000115	0.000451	CcSEcCtD
Terazosin—Paraesthesia—Methotrexate—lung cancer	0.000115	0.00045	CcSEcCtD
Terazosin—Discomfort—Doxorubicin—lung cancer	0.000114	0.000448	CcSEcCtD
Terazosin—Dyspnoea—Methotrexate—lung cancer	0.000114	0.000447	CcSEcCtD
Terazosin—Somnolence—Methotrexate—lung cancer	0.000114	0.000446	CcSEcCtD
Terazosin—Dry mouth—Doxorubicin—lung cancer	0.000113	0.000443	CcSEcCtD
Terazosin—Vomiting—Docetaxel—lung cancer	0.000113	0.000442	CcSEcCtD
Terazosin—Dyspepsia—Methotrexate—lung cancer	0.000112	0.000441	CcSEcCtD
Terazosin—Rash—Docetaxel—lung cancer	0.000112	0.000439	CcSEcCtD
Terazosin—Dermatitis—Docetaxel—lung cancer	0.000112	0.000438	CcSEcCtD
Terazosin—Confusional state—Doxorubicin—lung cancer	0.000112	0.000438	CcSEcCtD
Terazosin—Decreased appetite—Methotrexate—lung cancer	0.000111	0.000436	CcSEcCtD
Terazosin—Headache—Docetaxel—lung cancer	0.000111	0.000436	CcSEcCtD
Terazosin—Oedema—Doxorubicin—lung cancer	0.000111	0.000434	CcSEcCtD
Terazosin—Anaphylactic shock—Doxorubicin—lung cancer	0.000111	0.000434	CcSEcCtD
Terazosin—Fatigue—Methotrexate—lung cancer	0.00011	0.000432	CcSEcCtD
Terazosin—Pain—Methotrexate—lung cancer	0.000109	0.000429	CcSEcCtD
Terazosin—Shock—Doxorubicin—lung cancer	0.000109	0.000427	CcSEcCtD
Terazosin—Thrombocytopenia—Doxorubicin—lung cancer	0.000108	0.000425	CcSEcCtD
Terazosin—Tachycardia—Doxorubicin—lung cancer	0.000108	0.000424	CcSEcCtD
Terazosin—Hyperhidrosis—Doxorubicin—lung cancer	0.000107	0.00042	CcSEcCtD
Terazosin—Anorexia—Doxorubicin—lung cancer	0.000105	0.000414	CcSEcCtD
Terazosin—Nausea—Docetaxel—lung cancer	0.000105	0.000413	CcSEcCtD
Terazosin—Feeling abnormal—Methotrexate—lung cancer	0.000105	0.000413	CcSEcCtD
Terazosin—Gastrointestinal pain—Methotrexate—lung cancer	0.000105	0.00041	CcSEcCtD
Terazosin—Hypotension—Doxorubicin—lung cancer	0.000103	0.000406	CcSEcCtD
Terazosin—Abdominal pain—Methotrexate—lung cancer	0.000101	0.000396	CcSEcCtD
Terazosin—Body temperature increased—Methotrexate—lung cancer	0.000101	0.000396	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000101	0.000396	CcSEcCtD
Terazosin—Insomnia—Doxorubicin—lung cancer	0.0001	0.000393	CcSEcCtD
Terazosin—Paraesthesia—Doxorubicin—lung cancer	9.94e-05	0.00039	CcSEcCtD
Terazosin—Dyspnoea—Doxorubicin—lung cancer	9.87e-05	0.000387	CcSEcCtD
Terazosin—Somnolence—Doxorubicin—lung cancer	9.84e-05	0.000386	CcSEcCtD
Terazosin—Dyspepsia—Doxorubicin—lung cancer	9.74e-05	0.000382	CcSEcCtD
Terazosin—Decreased appetite—Doxorubicin—lung cancer	9.62e-05	0.000378	CcSEcCtD
Terazosin—Fatigue—Doxorubicin—lung cancer	9.54e-05	0.000374	CcSEcCtD
Terazosin—Pain—Doxorubicin—lung cancer	9.46e-05	0.000371	CcSEcCtD
Terazosin—Constipation—Doxorubicin—lung cancer	9.46e-05	0.000371	CcSEcCtD
Terazosin—Hypersensitivity—Methotrexate—lung cancer	9.42e-05	0.00037	CcSEcCtD
Terazosin—Asthenia—Methotrexate—lung cancer	9.17e-05	0.00036	CcSEcCtD
Terazosin—Feeling abnormal—Doxorubicin—lung cancer	9.12e-05	0.000358	CcSEcCtD
Terazosin—Gastrointestinal pain—Doxorubicin—lung cancer	9.05e-05	0.000355	CcSEcCtD
Terazosin—Pruritus—Methotrexate—lung cancer	9.04e-05	0.000355	CcSEcCtD
Terazosin—Body temperature increased—Doxorubicin—lung cancer	8.75e-05	0.000343	CcSEcCtD
Terazosin—Abdominal pain—Doxorubicin—lung cancer	8.75e-05	0.000343	CcSEcCtD
Terazosin—Diarrhoea—Methotrexate—lung cancer	8.74e-05	0.000343	CcSEcCtD
Terazosin—Dizziness—Methotrexate—lung cancer	8.45e-05	0.000332	CcSEcCtD
Terazosin—Hypersensitivity—Doxorubicin—lung cancer	8.15e-05	0.00032	CcSEcCtD
Terazosin—Vomiting—Methotrexate—lung cancer	8.13e-05	0.000319	CcSEcCtD
Terazosin—Rash—Methotrexate—lung cancer	8.06e-05	0.000316	CcSEcCtD
Terazosin—Dermatitis—Methotrexate—lung cancer	8.05e-05	0.000316	CcSEcCtD
Terazosin—Headache—Methotrexate—lung cancer	8.01e-05	0.000314	CcSEcCtD
Terazosin—Asthenia—Doxorubicin—lung cancer	7.94e-05	0.000312	CcSEcCtD
Terazosin—Pruritus—Doxorubicin—lung cancer	7.83e-05	0.000307	CcSEcCtD
Terazosin—Nausea—Methotrexate—lung cancer	7.59e-05	0.000298	CcSEcCtD
Terazosin—Diarrhoea—Doxorubicin—lung cancer	7.57e-05	0.000297	CcSEcCtD
Terazosin—Dizziness—Doxorubicin—lung cancer	7.32e-05	0.000287	CcSEcCtD
Terazosin—Vomiting—Doxorubicin—lung cancer	7.04e-05	0.000276	CcSEcCtD
Terazosin—Rash—Doxorubicin—lung cancer	6.98e-05	0.000274	CcSEcCtD
Terazosin—Dermatitis—Doxorubicin—lung cancer	6.97e-05	0.000274	CcSEcCtD
Terazosin—Headache—Doxorubicin—lung cancer	6.93e-05	0.000272	CcSEcCtD
Terazosin—Nausea—Doxorubicin—lung cancer	6.57e-05	0.000258	CcSEcCtD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.52e-05	0.000285	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PIK3CG—lung cancer	1.51e-05	0.000282	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GNG11—lung cancer	1.5e-05	0.000281	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—FLT1—lung cancer	1.49e-05	0.000278	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IGF1R—lung cancer	1.48e-05	0.000277	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.48e-05	0.000276	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—PIK3CG—lung cancer	1.47e-05	0.000276	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—CXCL8—lung cancer	1.47e-05	0.000275	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—PIK3CD—lung cancer	1.46e-05	0.000273	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NOTCH3—lung cancer	1.46e-05	0.000272	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—APP—lung cancer	1.46e-05	0.000272	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HES1—lung cancer	1.45e-05	0.000272	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—FGF9—lung cancer	1.44e-05	0.00027	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—POMC—lung cancer	1.43e-05	0.000268	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ALDOA—lung cancer	1.43e-05	0.000267	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—RAF1—lung cancer	1.42e-05	0.000267	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	1.42e-05	0.000266	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—STK11—lung cancer	1.41e-05	0.000264	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—IL2—lung cancer	1.41e-05	0.000263	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—POMC—lung cancer	1.4e-05	0.000262	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—IL6R—lung cancer	1.4e-05	0.000262	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—PIK3CB—lung cancer	1.39e-05	0.00026	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—NCOA3—lung cancer	1.39e-05	0.00026	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—JUNB—lung cancer	1.38e-05	0.000258	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—FOXO3—lung cancer	1.36e-05	0.000255	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ADCY1—lung cancer	1.35e-05	0.000253	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ABCG2—lung cancer	1.35e-05	0.000253	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PIK3CG—lung cancer	1.34e-05	0.00025	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CXCL8—lung cancer	1.34e-05	0.00025	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—MAP2K1—lung cancer	1.33e-05	0.000249	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—ERBB3—lung cancer	1.33e-05	0.000248	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PIK3CD—lung cancer	1.32e-05	0.000248	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—HPGDS—lung cancer	1.32e-05	0.000248	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ENO2—lung cancer	1.32e-05	0.000248	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PPP2R1B—lung cancer	1.32e-05	0.000246	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—PIK3CD—lung cancer	1.29e-05	0.000242	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GSTT1—lung cancer	1.28e-05	0.00024	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—IL2—lung cancer	1.28e-05	0.000239	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—AVP—lung cancer	1.27e-05	0.000239	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—POMC—lung cancer	1.27e-05	0.000238	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TERT—lung cancer	1.27e-05	0.000238	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—PIK3CB—lung cancer	1.27e-05	0.000238	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CYP2A6—lung cancer	1.27e-05	0.000238	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GCLC—lung cancer	1.27e-05	0.000238	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—STK11—lung cancer	1.25e-05	0.000234	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.25e-05	0.000233	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—IL6R—lung cancer	1.24e-05	0.000232	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—FGFR1—lung cancer	1.24e-05	0.000231	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IGF1R—lung cancer	1.23e-05	0.00023	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—CXCL8—lung cancer	1.22e-05	0.000229	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HIF1A—lung cancer	1.22e-05	0.000228	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—FOXO3—lung cancer	1.21e-05	0.000226	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HES1—lung cancer	1.2e-05	0.000226	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ENO1—lung cancer	1.2e-05	0.000225	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	1.2e-05	0.000225	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—MAP2K1—lung cancer	1.18e-05	0.000222	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—RAF1—lung cancer	1.18e-05	0.000221	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PIK3CD—lung cancer	1.18e-05	0.00022	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—APOA1—lung cancer	1.17e-05	0.00022	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—IL2—lung cancer	1.17e-05	0.000218	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—KDR—lung cancer	1.16e-05	0.000218	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PIK3CB—lung cancer	1.15e-05	0.000216	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—AVP—lung cancer	1.13e-05	0.000212	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—PIK3CB—lung cancer	1.13e-05	0.000211	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	1.12e-05	0.000211	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CXCL8—lung cancer	1.11e-05	0.000208	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ERBB3—lung cancer	1.1e-05	0.000206	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IGF1R—lung cancer	1.09e-05	0.000204	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CXCL8—lung cancer	1.08e-05	0.000203	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CYP2E1—lung cancer	1.08e-05	0.000202	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PIK3CG—lung cancer	1.07e-05	0.000201	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—APC—lung cancer	1.07e-05	0.000201	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—KIT—lung cancer	1.07e-05	0.000201	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—NRAS—lung cancer	1.07e-05	0.000201	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HES1—lung cancer	1.07e-05	0.0002	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—NQO1—lung cancer	1.07e-05	0.0002	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—IL2—lung cancer	1.06e-05	0.000198	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—EGF—lung cancer	1.06e-05	0.000198	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TERT—lung cancer	1.06e-05	0.000198	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—RAF1—lung cancer	1.05e-05	0.000196	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—IL2—lung cancer	1.04e-05	0.000194	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—MAPK3—lung cancer	1.03e-05	0.000192	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—FGFR1—lung cancer	1.03e-05	0.000192	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PIK3CB—lung cancer	1.02e-05	0.000192	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—POMC—lung cancer	1.02e-05	0.000191	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	1.02e-05	0.00019	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HIF1A—lung cancer	1.01e-05	0.000189	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—BRAF—lung cancer	1.01e-05	0.000189	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IL6R—lung cancer	9.95e-06	0.000186	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CREBBP—lung cancer	9.94e-06	0.000186	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CXCL8—lung cancer	9.85e-06	0.000184	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ERBB3—lung cancer	9.78e-06	0.000183	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—EGFR—lung cancer	9.76e-06	0.000183	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—APOA1—lung cancer	9.74e-06	0.000182	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—KDR—lung cancer	9.66e-06	0.000181	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—STK11—lung cancer	9.62e-06	0.00018	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MAP2K1—lung cancer	9.48e-06	0.000178	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PIK3CD—lung cancer	9.42e-06	0.000176	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—IL2—lung cancer	9.41e-06	0.000176	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TERT—lung cancer	9.38e-06	0.000176	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—PIK3CA—lung cancer	9.33e-06	0.000175	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—KRAS—lung cancer	9.22e-06	0.000173	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—FGFR1—lung cancer	9.11e-06	0.00017	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HIF1A—lung cancer	8.97e-06	0.000168	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GSTP1—lung cancer	8.9e-06	0.000167	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—APC—lung cancer	8.9e-06	0.000167	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—KIT—lung cancer	8.9e-06	0.000167	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PIK3CG—lung cancer	8.9e-06	0.000167	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—NRAS—lung cancer	8.9e-06	0.000167	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—EGF—lung cancer	8.79e-06	0.000165	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CAT—lung cancer	8.66e-06	0.000162	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—APOA1—lung cancer	8.65e-06	0.000162	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—KDR—lung cancer	8.58e-06	0.000161	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—MAPK3—lung cancer	8.52e-06	0.000159	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—PIK3CA—lung cancer	8.47e-06	0.000159	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—POMC—lung cancer	8.47e-06	0.000158	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MDM2—lung cancer	8.44e-06	0.000158	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—RAF1—lung cancer	8.41e-06	0.000157	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—BRAF—lung cancer	8.36e-06	0.000157	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—ERBB2—lung cancer	8.32e-06	0.000156	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—TYMS—lung cancer	8.27e-06	0.000155	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IL6R—lung cancer	8.26e-06	0.000155	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CREBBP—lung cancer	8.25e-06	0.000154	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MTOR—lung cancer	8.21e-06	0.000154	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PIK3CB—lung cancer	8.21e-06	0.000154	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GSTM1—lung cancer	8.18e-06	0.000153	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—EGFR—lung cancer	8.1e-06	0.000152	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—APC—lung cancer	7.9e-06	0.000148	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PIK3CG—lung cancer	7.9e-06	0.000148	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—KIT—lung cancer	7.9e-06	0.000148	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—NRAS—lung cancer	7.9e-06	0.000148	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CXCL8—lung cancer	7.89e-06	0.000148	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MAP2K1—lung cancer	7.87e-06	0.000147	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—HRAS—lung cancer	7.84e-06	0.000147	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PIK3CD—lung cancer	7.82e-06	0.000146	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—EGF—lung cancer	7.81e-06	0.000146	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CYP1A1—lung cancer	7.75e-06	0.000145	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—PIK3CA—lung cancer	7.75e-06	0.000145	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ERCC2—lung cancer	7.69e-06	0.000144	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—KRAS—lung cancer	7.66e-06	0.000143	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—AKT1—lung cancer	7.62e-06	0.000143	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—MAPK3—lung cancer	7.57e-06	0.000142	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CASP3—lung cancer	7.55e-06	0.000141	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IL2—lung cancer	7.54e-06	0.000141	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—POMC—lung cancer	7.52e-06	0.000141	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—IL6—lung cancer	7.5e-06	0.00014	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—BRAF—lung cancer	7.43e-06	0.000139	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CCND1—lung cancer	7.35e-06	0.000138	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IL6R—lung cancer	7.34e-06	0.000137	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—JUN—lung cancer	7.34e-06	0.000137	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CREBBP—lung cancer	7.33e-06	0.000137	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—EGFR—lung cancer	7.2e-06	0.000135	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MMP9—lung cancer	7.14e-06	0.000134	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CDKN1A—lung cancer	7.11e-06	0.000133	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PTEN—lung cancer	7.1e-06	0.000133	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PIK3CA—lung cancer	7.03e-06	0.000132	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MDM2—lung cancer	7.01e-06	0.000131	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MAP2K1—lung cancer	6.99e-06	0.000131	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—RAF1—lung cancer	6.98e-06	0.000131	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PIK3CD—lung cancer	6.95e-06	0.00013	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—AKT1—lung cancer	6.92e-06	0.00013	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ERBB2—lung cancer	6.91e-06	0.000129	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—PIK3CA—lung cancer	6.88e-06	0.000129	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MTOR—lung cancer	6.82e-06	0.000128	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PIK3CB—lung cancer	6.82e-06	0.000128	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—KRAS—lung cancer	6.8e-06	0.000127	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—EP300—lung cancer	6.77e-06	0.000127	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—APOA1—lung cancer	6.65e-06	0.000124	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—SRC—lung cancer	6.58e-06	0.000123	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CXCL8—lung cancer	6.55e-06	0.000123	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—HRAS—lung cancer	6.51e-06	0.000122	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—VEGFA—lung cancer	6.41e-06	0.00012	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—STAT3—lung cancer	6.35e-06	0.000119	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NRAS—lung cancer	6.33e-06	0.000119	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—AKT1—lung cancer	6.33e-06	0.000118	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CASP3—lung cancer	6.27e-06	0.000117	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IL2—lung cancer	6.26e-06	0.000117	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PIK3CA—lung cancer	6.25e-06	0.000117	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—IL6—lung cancer	6.23e-06	0.000117	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MDM2—lung cancer	6.22e-06	0.000116	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—RAF1—lung cancer	6.2e-06	0.000116	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ERBB2—lung cancer	6.14e-06	0.000115	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCND1—lung cancer	6.1e-06	0.000114	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—JUN—lung cancer	6.09e-06	0.000114	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PIK3CG—lung cancer	6.07e-06	0.000114	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MAPK3—lung cancer	6.06e-06	0.000113	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PIK3CB—lung cancer	6.05e-06	0.000113	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MTOR—lung cancer	6.05e-06	0.000113	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MMP9—lung cancer	5.92e-06	0.000111	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CDKN1A—lung cancer	5.9e-06	0.000111	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MYC—lung cancer	5.9e-06	0.00011	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PTEN—lung cancer	5.89e-06	0.00011	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CXCL8—lung cancer	5.82e-06	0.000109	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—HRAS—lung cancer	5.78e-06	0.000108	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—POMC—lung cancer	5.78e-06	0.000108	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—EGFR—lung cancer	5.77e-06	0.000108	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—AKT1—lung cancer	5.75e-06	0.000108	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CREBBP—lung cancer	5.63e-06	0.000105	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—AKT1—lung cancer	5.62e-06	0.000105	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—EP300—lung cancer	5.62e-06	0.000105	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CASP3—lung cancer	5.57e-06	0.000104	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IL2—lung cancer	5.56e-06	0.000104	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—IL6—lung cancer	5.53e-06	0.000104	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SRC—lung cancer	5.46e-06	0.000102	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—KRAS—lung cancer	5.45e-06	0.000102	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCND1—lung cancer	5.42e-06	0.000101	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—JUN—lung cancer	5.41e-06	0.000101	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PIK3CD—lung cancer	5.34e-06	9.99e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—VEGFA—lung cancer	5.32e-06	9.96e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ALB—lung cancer	5.27e-06	9.86e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—STAT3—lung cancer	5.27e-06	9.86e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MMP9—lung cancer	5.26e-06	9.85e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NRAS—lung cancer	5.25e-06	9.84e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CDKN1A—lung cancer	5.24e-06	9.82e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PTEN—lung cancer	5.23e-06	9.79e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—AKT1—lung cancer	5.1e-06	9.55e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MAPK3—lung cancer	5.03e-06	9.42e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PIK3CA—lung cancer	5.01e-06	9.37e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—EP300—lung cancer	4.99e-06	9.34e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MYC—lung cancer	4.89e-06	9.16e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SRC—lung cancer	4.85e-06	9.08e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TP53—lung cancer	4.84e-06	9.07e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—EGFR—lung cancer	4.79e-06	8.96e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—VEGFA—lung cancer	4.73e-06	8.85e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—STAT3—lung cancer	4.68e-06	8.76e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NRAS—lung cancer	4.67e-06	8.74e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PIK3CB—lung cancer	4.65e-06	8.71e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HRAS—lung cancer	4.63e-06	8.67e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PTGS2—lung cancer	4.61e-06	8.63e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—KRAS—lung cancer	4.52e-06	8.47e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MAPK3—lung cancer	4.47e-06	8.37e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IL6—lung cancer	4.43e-06	8.3e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MYC—lung cancer	4.35e-06	8.14e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—EGFR—lung cancer	4.25e-06	7.96e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PIK3CA—lung cancer	4.16e-06	7.78e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—AKT1—lung cancer	4.09e-06	7.66e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PTEN—lung cancer	4.02e-06	7.52e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TP53—lung cancer	4.02e-06	7.52e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—KRAS—lung cancer	4.02e-06	7.52e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HRAS—lung cancer	3.84e-06	7.2e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—EP300—lung cancer	3.83e-06	7.18e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PIK3CA—lung cancer	3.69e-06	6.91e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IL6—lung cancer	3.68e-06	6.89e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TP53—lung cancer	3.57e-06	6.68e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HRAS—lung cancer	3.41e-06	6.39e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—AKT1—lung cancer	3.39e-06	6.35e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IL6—lung cancer	3.27e-06	6.12e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—AKT1—lung cancer	3.02e-06	5.64e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PIK3CA—lung cancer	2.84e-06	5.31e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—AKT1—lung cancer	2.32e-06	4.34e-05	CbGpPWpGaD
